Nigeria Pharmaceutical Industry is projected to Expand at a CAGR of 9.1% during eh forecast period (2016-2024)

New York, USA, 2018-Dec-06 — /EPR Network/ — According to Goldstein Research, regional government initiatives to curb the import and distribution of counterfeit medicines and significant investment by the government to develop a matured business environment are the major factors for the growth of Nigeria pharmaceutical industry in the country. Nigeria Pharmaceutical Market outlook also includes statistics of branded and generic drugs along with the details of ongoing projects in the pharmaceutical sector in Nigeria. However, poor healthcare infrastructure, the inflow of counterfeit and substandard drugs and inadequate funding of the public system will continue to hinder the growth of Nigeria pharmaceutical industry.

Browse Full Report:

https://www.goldsteinresearch.com/report/nigeria-pharmaceutical-market-industry-analysis

Market Segmentation

On the basis of our in-depth analysis, Nigeria pharmaceutical market can be segmented as follows:

By Type

  • Active Pharmaceutical Ingredients (APIs)
  • Branded
  • Generics
  • Contract Research and Manufacturing Services
  • Formulations (CRAMS)
  • Chronic
  • Cardiovascular
  • Anti-Diabetes
  • Gastro Intestinal
  • Neurological
  • Acute
  • Anti-infectives
  • Respiratory
  • Pain
  • Gynecology
  • Biosimilars

“Nigeria Pharmaceutical Market Outlook 2024” contains detailed overview of the Nigeria Pharmaceutical market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by active pharmaceutical ingredients, contract research and manufacturing Services, formulations (CRAMS) and biosmililars.

Download Exclusive Sample Report:

https://www.goldsteinresearch.com/request-sample/nigeria-pharmaceutical-market-industry-analysis

Further, for the in-depth analysis, Nigeria Pharmaceutical Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Sun Pharma, Cipla, Candila. Glenmark, GlaxoSmithkline, Abbott Nigeria, Biocon, Jubilant life andSanofi Nigeria. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the Nigeria pharmaceutical market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players examining possibilities and other stakeholders to bring into line their market-centric approaches according to the ongoing and expected trends in the future.

Nigeria Pharmaceutical Market is driving on the basis of advancement in mentioned below industries:

India Pharmaceutical Market

 India Pharmaceutical Market size is anticipated to cross USD 76.7 billion by 2024, growing at a CAGR of 15.9% over the forecast period 2016-2024. More deals are expected to happen in Indian companies acquiring assets in US/Europe, rather than MNCs acquiring Indian companies. The India pharmaceuticals market size is set to reach USD 76.7 billion by 2024, at a CAGR of 15.9% over the forecast years

Global Biopharmaceutical and Biomedicine Market

Biopharmaceuticals & biomedicine deals with the research and development of drugs (biologics) partially or completely using biological compounds. The year 2017 has witnessed huge growth in the Biopharmaceutical Market. Biomedicines are increasingly penetrating the market as the drug manufacturers and other pharmaceutical companies are inclining towards R&D of biomedicine.

Global Pharmaceutical Herbal Extracts Market

Pharmaceuticals Herbal Extracts Market has immense growth prospects all over the world since ancient times, majorly in the Asia Pacific region. Herbal Extracts Market is mounting at a CAGR of 7.09% during the forecast period 2017-2025. Goldstein Research analyst forecast the pharmaceutical herbal extracts market size is set to reach nearly USD 10 billion by 2025, growing at a CAGR of 8.2% over the forecast period.

Singapore Pharmaceuticals Market

Singapore Pharmaceuticals Market anticipated to reach a market size of USD 530 billion, growing at a CAGR of 6.40% over the forecast period 2016-2024. Growth in adoption of modern healthcare technology and high demand for efficient healthcare system coupled with strong reimbursement policies is positively impacting the growth of Singapore pharmaceutical industry.

 

Matched content

Editor’s pick

Express Press Release Distribution